BIT's 16th Annual Congress of International Drug Discovery Science & Technology-China 2018
★ Scientific Program

BIT's 16th Annual World Congress of

Drug Discovery Science & Technology - Jinan 2018

Theme: Focusing on Biomedical Frontiers, Driving Industrial Innovative Development

Time: November 6-8, 2018

Place: Jinan, China

Preliminary Scientific Program


Session times on those days will not be finalized until the overall program schedule is completed.

Program Sessions (Please click each Forum for detailed program information)

Stream 1: Masters' Mind Honor Hall

Stream 2: High-end Dialogue

Stream 3: Breaking Research of Drug Discovery

Stream 4: New Drug R & D for Major Diseases

Stream 5: Industrial Art Gallery

Stream 6: Young Pharmacists’ Nexus

Stream 7: Projects Matchmaking


Stream 7: Project Matchmaking Event

Time:14:00-17:00, Nov. 6, 2018 
Place: Grand Ballroom, 2nd Floor, Sheraton Jinan Hotel, Jinan, China


Speech and Policy Statement


Project 1: JWA Gene Based Peptide/Small Molecular Compound Anti-Cancer Drugs

Dr. Jianwei Zhou, Professor, Nanjing Medical University, China


Project 2: Small Molecule Isocitrate Dehydrogenase (IDH)-2 Inhibitor for Acute Myelocytic Leukemia

Dr. Haixuan Liu, Project Manager, Nanjing Sanhome Pharmaceutical Co., Ltd., China


Project 3: Multiple Drug Discovery and Development Projects in Oncology

Dr. Guosheng Wu, Vice President, Pharmaron, China

Project 4: Preclinical development of new PPARγ Agonists for the Treatment of Alzheimer's Disease

Dr. Lihai Zhang, CEO, Shanghai Elixiria Biotech Co., Ltd.,USA

Project 5: High Uric Acid Gout Treatment 2018

Dr. Haiping Chen, Vice Chief Engineer, AMERICA P&G CO, USA
15:45-17:00  Free Docking

No. Project Title
1 Fatty Liver Drug Discovery
2 The Flavonoid Myricetin Present in an Enriched Polyphenol Extract of Syzigium (L) Skeels as a Novel Platelet Anti-Aggregant Drug
3 Screening and Validation for Anti-metastasis Drugs
4 Novel Liposomal Drug Delivery Technology
5 Multiple Drug Discovery and Development Projects in Oncology
6 Remote Management of Biosystems via the Digitized Biohologram of the Human Embryonic Stem Cell Based upon the Wave Optics of Chromosomes via Laser Polarized Bioholography
7 Biomarker for IGF-1 Function Associated Medical Conditions
8 Rational Design of New Small Antimicrobial Chemotherapeutics
9 Topical Drug Delivery in Medicine and Cosmetics with Degradable Particles
10 Out-license, Joint venture, Co-development, or Fee-For-Services of Promising Biopharmaceutical Products and Devices Originating from Non-US Companies into US
11 Structure and Ligand Based Designing of New Motif of PETT Derivatives for Anti-HIV Activity
12 Preclinical Development of New PPAR agonists for the Treatment of Alzheimer's Disease
13 Electrochemical Determination of Bisphenol A based on Gold Nanoparticles Modified Glassy Carbon Electrode
14 QTc Detection on EKG: Preventing 100,000 Medication Deaths/yr. Using Bluetooth Technology in Pharmacies
15 Global Problem Indian Solution to via New Generation Immunity Drug Receptol
16 Synthesis, Docking and Phenotypic Screening of Novel Biphenyl Analogues as Estrogen Receptor Agonists to Combat Tamoxifen Resistance in Breast Cancer Patients.
17 A Fusion Monoclonal Antibody Targeting the Tumor and the Microenvironment.
18 Liver-targeting Pyruvate Dehydrogenase Kinase Inhibitors
19 Development of the Effective Structure Activity Models and Structure based molecular modeling of Benzodiazepine Receptor Ligands
20 Topical PDE5I gels (TR399/TR422) for erectile dysfunction and pulmonary arterial hypertension
21 Development of diagnostic and prognostic biomarkers for colorectal cancer liver metastasis
22 Therapeutic mRNA Lung Cancer Vaccine
23 High uric acid gout treatment 2018
24 EHT in action with the Elderly: Cognition and self-reported state of being
25 MELANOMA Carcinogenic SKIN Organ-on-a-chip
26 Artificial Intelligence Driven New Cancer Therapy and Tool Development; Making Precision Cancer Medicine More Precise
27 Clinical Transformation and Further Research and Development of Tumor Infiltrating Lymphocytes
28 Protein Structure Fingerprint technology
29 Co-Development and Licensing of Patented Anti-Cancer Small Molecule Drugs for China Market
30 Development and Application of Gene Drug Introduction Technology
31 Discrete mathematical modeling and new method for information evaluation different type of structures
32 Junjing Peptide Oral Antibacterial Spray
34 Dr. JOE Natural Plant No Side Effects Of Health Products Research And Development
35 Aldo-Keto Reductases-Mediated Anticancer Drugs
36 Oramed Pharmaceuticals – Oral Insulin
37 Small Molecule Isocitrate Dehydrogenase (IDH)-2 Inhibitor for Acute Myelocytic Leukemia (AML)
38 Novel Cytotoxic Payloads for Antibody-drug Conjugates
39 Two First-in-class Anticancer Drug Candidates
40 KBTE Medical Laser Device
41 Kostovic/Tesla Electric Engine-mobile Hydroelectric Power Station
42 Automatic And Intelligent Detection System For Tumor Markers In Liquid Biopsy
43 R &D And Industrialization of Digital Medical Imaging Special Display Products
44 Intelligent Wearable Transcutaneous Electrical Stimulation Products
45 Industrialization of a New Generation of Non-invasive Electronic Blood Glucose Meters
46 German Telemedicine - Medical Imaging Radiology Diagnosis and Treatment
47 Characteristic Spinal Conditioning Technology
48 Research and Development of Pure Chinese Medicine Health Drink and Japanese Wild Sika Deer Series
49 Develop Chinese Medicine for Curing AIDS
50 Primary Adult (Functionally Mature) Brain Cells��Mammals��
51 Cloud Computing-based Psychology Technology Application Big Data Platform
52 Cloud Data Medical Health and Personalized Services
53 Insect Nutrition Powder
54 The Chinese Center Project of the Life Science Academy of the Global Overseas Chinese Alliance
55 JWA Gene Based Peptide/Small Molecular Compound Anti-Cancer Drugs


News Release
Full Program Released 说明:
● Call for Supporting Organizations and Media Partners
● Call for Session Chairs and Speakers 
● Call for Exhibitors and Sponsors
Hosting Organizations

Information Research Center of International Talent, SAFEA

Jinan Innovation Zone
Supporting Organizations

Ji'nan Branch of China Council for The Promotion of International Trade

University of South Australia

School of Biological Engineering, Qilu University of Technology

Operating Organizations
Official Travel Agency
Participating Organizations

Amgen, Inc.
Arrowhead Pharmaceuticals Inc.
Eisai Co., Ltd.
ChemDiv, Inc.
University of Queensland
Comenius University
Fountain Medical Development Ltd.,
McGill University
Pharmaron Inc.
Pfizer Inc.
Florida State University
Shanghai Jiaotong University School of Medicine
Leydig, Voit & Mayer, Ltd.
University of Pittsburgh
F. Hoffmann-La Roche
Tactical Therapeutics, Inc.
Leadscope Inc.
AbbVie Deutschland GmbH & Co. KG
Merck KGaA
Genentech, Inc.
Hamamatsu Photonics K.K.
University of Arizona
ChemDiv, Inc
AbMax Biotechnology Inc.
University Hospital Brno and Medical Faculty of Masaryk University
PSMMC, Riyadh
Boehringer Ingelheim Pharma GmbH & Co. KG
Global PKPD & Pharmacometrics, Eli Lilly and Company
Beijing Institute of Pharmacology and Toxicology
Auckland UniVersity
Cyclenium Pharma Inc.
Helmholtz Centre for Infection Research
University of Arizona
Medlab Clinical Pty Ltd.
National Institute of Biological Sciences, Beijing
Quinnipiac University/King Lee PhD, LCC
Novartis Institue of Biomedical Research
IriSys, LLC,
Private Clinic of Dermatovenerology Svidník
Saarland University
Cardiff University

Media Partners

BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609-826, Fax: 0086-411-84796897
Copyright © 2017-2018 BIT Congress Inc.